Potential treatment for drug-resistant TB discovered
Darpan News Desk IANS, 25 Feb, 2015 12:05 PM
Researchers led by an Indian-origin scientist have developed a new drug that may serve as a treatment against multi-drug resistant tuberculosis, a form of the disease that cannot be cured with conventional therapies.
"Multi-drug resistant TB is spreading rapidly in many parts of the world," said lead author Vasu Nair, director, University of Georgia (UGA) Center for Drug Discovery.
"There is a tremendous need for new therapies, and we think our laboratory has developed a strong candidate that disrupts fundamental steps in the bacterium's reproduction process," Nair added.
Nine million people contracted tuberculosis in 2013, and 1.5 million died from the disease, according to the World Health Organisation (WHO).
While standard anti-TB drugs can cure most people of Mycobacterium tuberculosis infection, improper use of antibiotics has led to new strains of the bacterium resistant to the two most powerful medications, isoniazid and rifampicin.
"The compound we developed strongly inhibits the growth of the bacterium and renders it incapable of reproducing and spreading infection," Nair pointed out.
The researchers also performed extensive studies to determine if their newly developed compound had an appropriately long half-life and could be cleared from the body through normal biochemical mechanisms.
"More importantly, the compound shows very low levels of cytotoxicity, which means that it is not harmful to the body," Nair added.
The researchers found that the new compund also exhibited strong anti-HIV properties, opening the door for dual therapeutic applications.
"This discovery of dual activity against both retroviruses and drug-resistant gram-positive bacteria is unique and opens a new chapter in drug discovery in this area," Nair said.
The study was published in the journal Bioorganic and Medicinal Chemistry Letters.
How well parents understand the daily experiences of their teenagers is linked to the latter's physical and mental well-being, new research suggests....
Women who worry, cope poorly with stress and experience mood swings in middle age run a higher risk of developing Alzheimer's disease later in life, it showed....
Although rich in Omega-3 fatty acids, high doses of fish oil supplements do not reduce atrial fibrillation, a common type of irregular heartbeat, found...
Women who are treated for high blood pressure are not given the same medication as men nor do they hit the treatment targets as often, Swedish researchers say....
Personalised treatment for Type 2 diabetes could be available soon as researchers have found that yohimbin, a drug that was de-registered for several years...
A Dallas nurse being treated for Ebola has received a plasma transfusion from a doctor who beat his own infection with the deadly virus after getting a similar treatment. The reason: Antibodies in the blood of a survivor may help a patient fight off the germ.
